Hot penny stocks... don't get burned
   

News for Bradmer Pharmaceuticals Inc. (BMR)

Markets Quote Depth/LII Options Charts News Company Financials Insiders Filings Analyst Earnings Historical
Symbol: powered by
  quotemedia.com
News for Bradmer Pharmaceuticals Inc.  (BMR:CA) 
|
$ 0.19   0.005 (+2.70%) Volume: 23.0 k 3:24 PM EST Dec 4, 2008
Mon, Dec 01, 2008
8:02 AM Bradmer issued patent in Europe for use of Neuradiab(TM) to treat lymphoma - PR Newswire
8:00 AM Bradmer issued patent in Europe for use of Neuradiab(TM) to treat lymphoma - Canada NewsWire
Wed, Nov 19, 2008
11:21 AM Bradmer to present poster on progression free survival and overall survival data from Neuradiab(TM) Phase II trials at Society for Neuro-Oncology Meeting - PR Newswire
11:00 AM Bradmer to present poster on progression free survival and overall survival data from Neuradiab(TM) Phase II trials at Society for Neuro-Oncology Meeting - Canada NewsWire
Mon, Nov 10, 2008
4:05 PM Bradmer announces 2008 third quarter operational and financial results - PR Newswire
4:05 PM Bradmer announces 2008 third quarter operational and financial results - Canada NewsWire
Wed, Nov 05, 2008
2:00 PM Bradmer sponsors physician panel to raise awareness of brain cancer treatments - PR Newswire
2:00 PM Bradmer sponsors physician panel to raise awareness of brain cancer treatments - Canada NewsWire
Mon, Nov 03, 2008
4:27 PM Bradmer to present at Rodman & Renshaw Healthcare Conference - PR Newswire
4:27 PM Bradmer to present at Rodman & Renshaw Healthcare Conference - Canada NewsWire
Wed, Oct 01, 2008
3:06 PM Bradmer to present at BioContact Quebec 2008 - Canada NewsWire
Tue, Sep 30, 2008
7:01 AM Bradmer Announces Appointments to Board of Directors - PR Newswire
7:00 AM Bradmer Announces Appointments to Board of Directors - Canada NewsWire
Mon, Aug 11, 2008
7:01 AM Bradmer announces 2008 second quarter operational and financial results - PR Newswire
7:00 AM Bradmer announces 2008 second quarter operational and financial results - Canada NewsWire
Wed, Jul 23, 2008
7:01 AM Bradmer initiates enrollment in Phase III GLASS-ART Trial in primary glioblastoma multiforme - PR Newswire
7:00 AM Bradmer initiates enrollment in Phase III GLASS-ART Trial in primary glioblastoma multiforme - Canada NewsWire
Thu, Jul 17, 2008
7:01 AM Bradmer reports progression free survival data from previous Phase II glioblastoma multiforme trials - PR Newswire
7:00 AM Bradmer reports progression free survival data from previous Phase II glioblastoma multiforme trials - Canada NewsWire
Wed, Jun 04, 2008
7:00 AM [video] Wallst.net's '3 Minute Press Show' Features Executive Interviews and Highlights Recent Press for the Following: RBRM, CLKTF, BMR, CRO, PNCKF, CKM, CSAT - PR Newswire
Tue, Jun 03, 2008
8:19 AM Bradmer receives FDA approval to proceed with Phase III clinical trial - PR Newswire
8:18 AM Bradmer receives FDA approval to proceed with Phase III clinical trial - Canada NewsWire
Fri, May 09, 2008
7:00 AM Bradmer announces 2008 first quarter operational and financial results - PR Newswire
7:00 AM Bradmer announces 2008 first quarter operational and financial results - Canada NewsWire
Wed, Apr 02, 2008
7:01 AM Bradmer announces new additions to management team - PR Newswire
  Page 1 of 5   Next Page

Copyright © QuoteMedia.   Data delayed at least 15 min. unless otherwise indicated.   RT   Realtime,  EOD   End Of Day,  PD   Previous Day.   Market Data powered by QuoteMediaTerms of Use. 
   
Research Report
Hotstocked.com has a complete research report available for BMR stock. Download BMR report.
Research Report
Get the full report for FREE
Date:2008-09-01
Price:Free
Pages:4
Document Type:Adobe Acrobat Reader
 Download BMR report
  
Example preview: Research report for Bradmer Pharmaceuticals Inc. (BMR) Research report for Bradmer Pharmaceuticals Inc. (BMR) Research report for Bradmer Pharmaceuticals Inc. (BMR) Research report for Bradmer Pharmaceuticals Inc. (BMR)
   
   
 
Home > Companies > Bradmer Pharmaceuticals Inc.